Medtronic Hugo Robot Gains FDA Clearance for General Surgery

Medtronic announced on November 17, 2026 that the U.S. Food and Drug Administration had cleared its Hugo robotic-assisted surgery system for general surgery, extending the platform beyond urology into procedures the company estimates account for about 3.5 million U.S. surgeries each year. The expanded 510(k), a premarket notification route based on substantial equivalence to a legally marketed device, covers all upper-abdominal general surgical procedures. These include cholecystectomy…

This article has been indexed from Unite.AI